The Use of Solid Lipid Nanoparticles

Introduction Proteins accumulate in the nucleus and emit molecule-specific invasive signals through the nuclear pore complex (NPC) [1-3]. This mechanism was first observed in the nucleoprotein, an acidic protein that binds histone H2A and H2B during nucleosome construction [4-8]. In vertebrates, the nuclear pore complex has a mass of 125 Mda and comprises 50 to 100 polypeptides. Therefore, signal-mediated transport mechanism is required for macromolecules to pass through NPC. Although there are several pathways for nuclear transport, the classical nuclear localization signal (NLS) containing one or more basic amino acid clusters is well known and characterized [9].

Lipid nanoparticles are similar in size to commonly used emulsions, differing in size and structure in that the water-insoluble core is dispersed in a combination of surfactant-stabilized solid and liquid lipids It is an innovative delivery system. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC), as studied in this revision, are novel and promising nanocarriers that are very useful in the food sector due to their unique properties is there. .

Prescription and application of a new generation of lipid nanocarriers for biologically active ingredients of food

Lipid-based nanoparticles are small molecules such as amphotericin B, doxorubicin, vaccines, viruses and bacteria as nucleic acids. These are prepared by mixing the lipids together in an organic solution and then evaporating the solution. It is then hydrated and the liposomes are divided into small parts by ultrasound. Polymer-based nanoparticles are alkyl cyanoacrylates that are widely used as tissue adhesives for skin wounds and surgical gums. Polymer-based nanoparticles are less toxic as they degrade by hydrolysis of ester bonds. This hydrolysis or decomposition produces alkyl alcohol and cyanoacrylic acid. They are removed during kidney filtration.

Advances in lipid nanotechnology have helped engineering medical nanodevices and new drug delivery systems and developing sensing applications. Another system for microRNA delivery during preliminary investigation is nanoparticles formed by self-assembly of two different microRNAs that are dysregulated in cancer. Potential applications are based on small electromechanical systems such as nanoelectromechanical systems investigating active release and sensors of drugs for the treatment of cancer with iron nanoparticles or gold shells.